Abstract:Eman M Halawani, 1, 2, * Aziza M Hassan, 3, 4 Sanaa MF Gad El-Rab 3, 5, * 1 Division of Microbiology, Department of Biology, Faculty of Science, Taif University, Taif 21974, Saudi Arabia; 2 Yousef Abdullatif Jameel Chair of Prophetic Medicine Application, King Abdulaziz University, Jeddah, Saudi Arabia; 3 Department of Biotechnology, Faculty of Science, Taif University, Taif 21974, Saudi Arabia; 4 Cell Biology Department, National Research Centre, Dokki, Giza, Egypt; 5 Department of Botany and Microbiology, Faculty of Science, Assiut University, Assiut 71516, Egypt *These authors contributed equally to this work Correspondence: Sanaa MF Gad El-Rab Department of Biotechnology, Faculty of Science, Taif University, P.O. Box 888, Taif 21974, Saudi Arabia Tel +966558857908 Fax +966127433699 Email sanaa1996@yahoo.com Objectives: Due to the expanded bacterial genetic tolerance to antibiotics through different mechanisms, infectious diseases of MDR bacteria are difficult for treatment. Consequently, we synthesized drug conjugated nanoparticles to dissolve this problem. Moreover, the present study aims to display the cell death status treated with cefotaxime-CS-AgNPs and also, apoptosis pathways of human RPE-1 normal cells and human MCF-7 breast cancer cells. Methods: Here, we demonstrate the possibility to synthesize AgNPs and conjugate them with cefotaxime to survey the probability of cefotaxime-CS-AgNPs as an antimicrobial agent against cefotaxime-resistant strains E. coli and MRSA. Results: TEM showed the size of AgNPs, CS-AgNPs and cefotaxime-CS-AgNPs ranged from 7.42 to 18.3 nm, 8.05– 23.89 nm and 8.48– 25.3 nm, respectively, with a spherical shape. The cefotaxime-CS-AgNPs enhanced the high antimicrobial properties compared to AgNPs or pure antibiotic. The MIC of Cefotaxime-CS-AgNPs ranged from 3 μg/mL to 8 μg/mL against tested E. coli and MRSA bacteria. Consequently, the highest reduction in the MIC of cefotaxime-CS-AgNPs was noted against tested strains ranging from 22% to 96%. Comparing cefotaime-CS-AgNPs to AgNPs we showed that cefotaime-CS-AgNPs have no cytotoxic effect on normal cells at even 12 μg/mL for 24 hrs. The IC50 for the AgNPs and cefotaxime-CS-AgNPs was 12 μg/mL for human RPE-1 normal cells and human MCF-7 breast cancer cell lines. The pro-apoptotic genes p53, p21, and Bax of cancer cell lines significantly upregulated followed by downregulated by anti-apoptotic gene Bcl-2 after 48 hrs at 24 μg/mL, and this concentration represents the most effective dose. Conclusion: Results enhanced the conjugating utility in old unresponsive cefotaxime to AgNPs to restore its efficiency against previous strains and demonstrated potential therapeutic applications of cefotaxime-CS-AgNPs. Moreover, this research gives remarkable insights for designing nanoscale delivery and curative systems that have a pronounced cytotoxic activity on cancer cells and are safe to normal cells. Keywords: AgNPs and cefotaxime-Cs-AgNPs, MRSA, E. coli , anticancer, cytotoxicity, genotoxicity

Chemically synthesized ciprofloxacin-PEG-FeO nanotherapeutic exhibits strong antibacterial and controlled cytotoxic effects

Ciprofloxacin loaded PEG coated ZnO nanoparticles with enhanced antibacterial and wound healing effects

Ultrasound-Launched Targeted Nanoparticle Enhances Antibacterial Sonodynamic Therapy for Effective Eradication of Pseudomonas Aeruginosa Biofilm

Green synthesis of polyethylene glycol coated, ciprofloxacin loaded CuO nanoparticles and its antibacterial activity against Staphylococcus aureus

Ciprofloxacin-Loaded Silver Nanoparticles as Potent Nano-Antibiotics against Resistant Pathogenic Bacteria

Fabrication of Ciprofloxacin-Loaded Sodium Alginate Nanobeads Coated with Thiol-Anchored Chitosan Using B-390 Encapsulator Following Optimization by DoE

A systematized comparative account of antimicrobic explorations of ciprofloxacin couple of zinc oxide, copper and silver nanoparticles

Cefixime-Containing Silica Nanoseeds Coated by a Hybrid PVA-Gold Network with a Cys–Arg Dipeptide Conjugation: Enhanced Antimicrobial and Drug Release Properties

Enhancing efficacy of existing antibacterials against selected multiple drug resistant bacteria using cinnamic acid-coated magnetic iron oxide and mesoporous silica nanoparticles

Oxygen-supplied Mesoporous Carbon Nanoparticles for Enhanced Photothermal/photodynamic Synergetic Therapy Against Antibiotic-Resistant Bacterial Infections

A new strategy for the treatment of middle ear infection using ciprofloxacin/amoxicillin-loaded ethyl cellulose/polyhydroxybutyrate nanofibers

Enhanced wound healing of ciprofloxacin incorporated PVA/alginate/PAA electrospun nanofibers with antibacterial effects and controlled drug release

Design and Synthesis of Theranostic Antibiotic Nanodrugs That Display Enhanced Antibacterial Activity and Luminescence.

Ciprofloxacined peptided-based nanoparticles confer antimicrobial efficacy against multidrug-resistant bacteria

Lactoferrin/pectin nanocomplex encapsulating ciprofloxacin and naringin as a lung targeting antibacterial nanoplatform with oxidative stress alleviating effect

Tailoring ZnO nanoparticles for biomedical applications: Surface functionalization of ZnO nanoparticles with 2-oxo-2H-chromene-3-carboxylic acid coupled beta-cyclodextrin for enhanced antimicrobial and anticancer effect

Nanoformulation of Biogenic Cefotaxime-Conjugated-Silver Nanoparticles for Enhanced Antibacterial Efficacy Against Multidrug-Resistant Bacteria and Anticancer Studies

Bovine Serum Albumin - Hydroxyapatite Nanoflowers as Potential Local Drug Delivery System of Ciprofloxacin

Holistic Study Design Following Quality by Design Approach for Fabrication of Hybrid Polymeric Nanoparticulate Based Dry Powders as Carriers for Ciprofloxacin

Formulation of biodegradable alginate-based nano-carriers for in-vitro drug delivery and antibacterial activity

Development of Folic Acid Functionalized Carbon Nanotubes for Efficient Delivery of Curcumin and Quercetin Against Pathogenic Bacteria